+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Completed

Phase Not Applicable
Age: 18Years - 45Years
All Genders
ID00000897

The Effect of Oral and Injectable Contraceptives NorethindroneEthinyl Estradiol, Medroxyprogesterone Acetate and Gender on Plasma and Intracellular Zidovudine Pharmacokinetics

Led by National Institute of Allergy and Infectious Diseases (NIAID) · Updated on 2011-03-02

42

Participants Needed

6

Research Sites

N/A

Total Duration

AI-Summary

What this Trial Is About

The purpose of this study is to look at the effects of different methods of birth control (oral and injectable) on how the body absorbs, makes available, and removes zidovudine (ZDV). This study will also evaluate the differences in men and women in how the body absorbs, makes available, and removes ZDV. Past research has shown that the effectiveness of ZDV as an anti-HIV drug might be decreased in individuals who use certain methods of birth control. ZDV may also have different effects in men compared to women.

CONDITIONS

Brief Title

A Study to Evaluate the Effects of Different Methods of Birth Control on the Drug Actions of Zidovudine (an Anti-HIV Drug) in HIV-Positive Women and to Compare Zidovudine Metabolism in Men and Women

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here